Jason Lu, PhD, is an independent clinical-development professional based in Taiwan. He holds a PhD in Molecular Medicine from the University of Texas Health San Antonio and has professional experience spanning medical writing, clinical drug development, and sponsor-side clinical project management. His current work focuses on how AI is changing clinical-development workflows, evidence integration, project management, and decision accountability.
AI can draft a CSR in minutes, but the report only reflects evidence that has already converged, so faster drafting shifts the bottleneck to upstream reconciliation, database-lock readiness, and human accountability rather than shortening the trial itself.
